Q2 2011

Source filing unavailable

Q2 2011 · —

Revenue—

Net Income

-$293.00K

N/M vs Q2 2010

EPS Diluted

-$0.01

N/M vs Q2 2010

Gross Profit$4,656,000+18.9%

Operating Income-$114,000N/M

Operating Cash Flowderived$490,000—

Same quarter

Metric	Q2 2011	Q2 2010
Net Income	-$293.00K	-$978.00K
EPS Diluted	-$0.01	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR